Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. - Wikidata - awgldk - TriplyDB

Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.

Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.

http://www.wikidata.org/entity/Q35779268

about

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors The mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapes Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity Identifying and targeting tumor-initiating cells in the treatment of breast cancer Emerging role of cell polarity proteins in breast cancer progression and metastasis MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT)Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity Py2T murine breast cancer cells, a versatile model of TGFβ-induced EMT in vitro and in vivo Derivation of myoepithelial progenitor cells from bipotent mammary stem/progenitor cells Wnt-responsive cancer stem cells are located close to distorted blood vessels and not in hypoxic regions in a p53-null mouse model of human breast cancer.Prolactin cooperates with loss of p53 to promote claudin-low mammary carcinomas Re-expression of miR-200c suppresses proliferation, colony formation and in vivo tumor growth of murine claudin-low mammary tumor cells.Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts.Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling.A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer.Biocompatible nanopolymers: the next generation of breast cancer treatment?A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization Mouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomes MicroRNA-200 family modulation in distinct breast cancer phenotypes.Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer.Distinct luminal-type mammary carcinomas arise from orthotopic Trp53-null mammary transplantation of juvenile versus adult mice.A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer.Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways.The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells.BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells.Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype.DNA damage and breast cancer Mouse models of estrogen receptor-positive breast cancer Cytokeratin 5/6 fingerprinting in HER2-positive tumors identifies a poor prognosis and trastuzumab-resistant basal-HER2 subtype of breast cancer.Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation.Progress in breast cancer research.Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression.

P2860

Q21195201-FEB21B87-95C1-4A28-AFB3-48AB0648F39B Q24605597-79EE320A-2C1D-434C-956F-51A3E437248F Q26799993-124E2EA3-7232-40AB-B91D-83F96130B5DF Q26851620-F705E967-16FA-4239-B901-21EF202CAFB6 Q26851827-6C00447F-3602-45CB-8BFE-2EDAE53F4AE5 Q26851833-54D87B20-59A5-4F2E-B0AE-9654942F2ACF Q26853284-CD8B3BC5-D678-4914-B147-A9B6B1CABCF3 Q26864117-5FAC6A56-51E1-4DA8-B911-36102E676F3D Q27010233-2846EDF7-647D-46DD-A991-2947F082A79D Q27340972-4458C2A5-894E-4323-8566-256B35FA5973 Q28482309-35188AFF-9E92-45DD-8C17-1462D69EF343 Q30581875-88241E27-1B7D-4D4C-BBA6-D3FAA7CB96D0 Q33555787-5C5173CE-DF30-45A4-B3E0-F4ED8F968332 Q33618841-2E2E9519-CFDD-4704-8CA4-E678BE30DFAD Q33676275-263B2413-DA40-40F1-A99C-0D156EBCC516 Q33742688-0DBA04FF-665E-474C-8D20-3C2E96EB4AF8 Q33805247-91D5E8CF-B024-4169-85BE-71F8EBADADCF Q33835581-7D7A250C-25DF-4FE0-82EC-3D3B3C6139FA Q33864065-456069C5-8126-45D2-B8E5-087B2AF75C12 Q34209378-BB07DF06-BF0A-4073-BC02-D937EE49CDA6 Q34288822-480B05F2-B6D6-4242-AD96-8FBC8B0D465F Q34339847-D0AF2A5D-0CCD-4B3E-A661-5288F228F677 Q34374191-B1CED4C6-1C4A-4856-8D5C-333DAC47C094 Q34462262-7C6AAE10-A9C5-4A8E-AF69-593D5EE8FB74 Q34577891-52570BBF-42AA-480F-A014-0A963A805148 Q34616600-196486C7-36EE-4B03-A9B9-C2C333BCBAD2 Q34744122-68193BA1-4FDA-4ED3-8DAC-C4A3E83A1935 Q34769289-C4AFE259-C056-4B66-94FB-DD4930DFD153 Q34880928-8790F8F6-2588-45BE-829A-63FB7779DBB0 Q35000261-761762B6-FDB9-4643-8302-EDD104CD1044 Q35079440-CA8FC26B-7D0F-4B76-871E-90ED36BC06F7 Q35114304-99EFBEFB-1955-47B2-B5C3-15C5A0F07C83 Q35182598-59C9C4E7-561F-4CE9-9004-547AA34F5781 Q35201664-17777000-53DB-4102-8C88-DE95CC1D2DFB Q35685892-EBAB99F7-5839-4907-83B1-4DD8030E4A27 Q35740160-EE9B9FD5-4338-4B47-82A1-8224B946CC73 Q35775850-2632FC5E-FAE5-4216-B9CB-A0A45F5C2682 Q35779144-3DCE257E-7DDC-48D5-9DC5-F5EA831F51A1 Q35816299-73471844-D703-44EC-9C8E-CE83C8B0C5E6 Q35828457-6227F661-AB35-4A40-AFE5-1AD46388AFE0

P2860

Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.

http://www.wikidata.org/entity/Q35779268

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Comparative oncogenomics ident ...... tional tumor-initiating cells.

@ast

Comparative oncogenomics ident ...... tional tumor-initiating cells.

@en

type

label

Comparative oncogenomics ident ...... tional tumor-initiating cells.

@ast

Comparative oncogenomics ident ...... tional tumor-initiating cells.

@en

prefLabel

Comparative oncogenomics ident ...... tional tumor-initiating cells.

@ast

Comparative oncogenomics ident ...... tional tumor-initiating cells.

@en

P1433

Q35779268-96E5245F-2405-419D-AA92-91F0CBDA393D

P1476

Q35779268-D7529C34-132D-4BE6-83A3-06AA1692B8DE

P2093

Q35779268-06DE5714-6486-41CA-B1E1-77D02DE5ECC5

Q35779268-16EB21E3-A576-486A-84A6-45CB2A5441D1

Q35779268-185DD2BE-4265-4E37-A738-388C261CC52A

Q35779268-1F715FA7-A673-4C92-BC1E-36B8B430744B

Q35779268-26EB050B-2681-4F8A-B07D-10AF04CD043B

Q35779268-3B0655B5-21FC-4025-B9C5-8D656BD970DA

Q35779268-4797F932-C7E0-4ADC-BFD3-95FF1052B597

Q35779268-78C2BABB-26F5-4C2C-8791-C9777A776F16

Q35779268-A1C34375-47D1-4439-9358-483FA893EDC3

Q35779268-AE5B8349-932C-42C4-B2BE-A22F3E916D70

P2860

Q35779268-0D2BF531-EEF2-4791-82FD-9F84A7D32479

Q35779268-199C8781-42F1-4CCB-9931-F2920D89F9A2

Q35779268-1C5050CF-D37B-4C45-9930-94D05E75AD37

Q35779268-2139867C-A163-45D7-886F-B1766421782B

Q35779268-250F3913-0567-4700-9BDF-9A232FD83F4C

Q35779268-2AC66E4B-838B-4696-B072-D15A9114FADD

Q35779268-38A7AD52-906D-4E53-A5C5-F725E4AD75C9

Q35779268-3977A8D9-16A6-4D8E-9FB1-F53554B40B18

Q35779268-39E14327-B4EA-4EA3-9255-DF3F89FE7BF4

Q35779268-3B656673-6872-4C6F-817E-12BA99668855

P304

Q35779268-1F299DB0-3638-43F5-BD38-D46632902F76

P31

Q35779268-1094F40E-E631-460C-8D4A-633359C1CFA3

P356

Q35779268-2169B501-52D6-476A-B894-5192E1E333DF

P407

Q35779268-7E80B7FE-103F-4F50-A738-C4FF3BFEE632

P433

Q35779268-3DC46FBA-EE2A-4406-B50D-80CA4981FF22

P478

Q35779268-E244F4AB-FDC2-4800-AD92-A9D059C7B350

P50

Q35779268-8A505F85-3BDF-4A3A-BF1A-FCCCED03BDA3

P577

Q35779268-95052AA8-2082-436D-8F2E-ABC625F719FA

P5875

Q35779268-2212C2BB-5087-4231-9BCC-165BFF8F7084

P698

Q35779268-51D57FEE-D5D2-4BF4-ACCD-06476F8AF878

P932

Q35779268-D85A302A-E266-47C7-A5E4-0A994AAE03E1

P356

PNAS.1018862108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Comparative oncogenomics ident ...... tional tumor-initiating cells.

@en

P2093

Daniel Medina

http://www.w3.org/2001/XMLSchema#string

David Darr

http://www.w3.org/2001/XMLSchema#string

David Edwards

http://www.w3.org/2001/XMLSchema#string

George Murrow

http://www.w3.org/2001/XMLSchema#string

Jana Knezevic

http://www.w3.org/2001/XMLSchema#string

Jason I Herschkowitz

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Rosen

http://www.w3.org/2001/XMLSchema#string

Jerry Usary

http://www.w3.org/2001/XMLSchema#string

Mei Zhang

http://www.w3.org/2001/XMLSchema#string

Melissa A Troester

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

Cancer statistics, 2010

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Stem cells, cancer, and cancer stem cells

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

Repeated observation of breast tumor subtypes in independent gene expression data sets

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

Crypt stem cells as the cells-of-origin of intestinal cancer

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

P304

2778-2783

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1018862108

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Charles M. Perou

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51184301

http://www.w3.org/2001/XMLSchema#string

P698

21633010

http://www.w3.org/2001/XMLSchema#string

P932

3286979

http://www.w3.org/2001/XMLSchema#string